Tag:
pharma companies
Latest Headlines
Latest Headlines
Med school docs still break conflict-of-interest rules
While some medical schools continue to get smarter when it comes to implementing conflict-of-interest policies , as FierceHealthcare reported last Friday, many physicians at several prominent schools
Small physician groups slower to sever industry ties
While overall physician-industry ties remain strong, increased transparency and stricter rules surrounding such relationships have led to an across-the-board drop in drug-company payments to doctors
Investigation fans debate over physician-pharma ties
When doctors discuss what a medication can do, it confers a veneer of respectability on the drug company's marketing. But a ProPublica investigation uncovered that many the best paid physicians who
Surprising facts about pharma's best paid pill-pushing docs
When doctors discuss what a medication can do, it confers a veneer of respectability on the drug company's marketing. But a ProPublica investigation uncovered that fewer than half of the best paid
Studies raise questions about how much drug safety info should be released
Prescription scares have caused a number of sources, including the FDA, to release a lot more prescription safety information--but could it be too much information? Several recent studies have raised
ALSO NOTED: MN Gov. withdraws healthcare promise; Cancer patients take front line in early-stage trials; and much more...
> Minnesota Gov. Tim Pawlenty withdrew promised support for a bill designed to cut healthcare spending by nearly 20 percent by 2015, citing a lack of support from Republican House members.
ALSO NOTED: Consolidation in the medical tourism biz; LA county closing clinics; and much more...
> Consolidation is already happening in the medical tourism business: Greenwood Village, CO-based BridgeHealth International has agreed to buy New York-based Medical Tours International.
Merck agrees to pay$650M+ to settle suits
Merck has agreed to pay more than $650 million to settle two whistleblower suits, the U.S. Justice Department has announced. One of the suits claimed that the pharma paid providers to use its
Study:Many MDs won't see sales reps
A new study suggests that nearly one-fifth of office-based physicians refuse to see sales reps from the drug and device industry, and nearly 23 percent more won't see the reps unless they set an
VA removes Avandia from its formulary
VA dealt a body blow to type 2 diabetes drug Avandia this week, deciding that while it would continue to make the drug available to existing users, officials would no longer allow it to be prescribed
